Moderna says Covid-19 vaccine shields against British, South African strains - La Prensa Latina Media

 American pharmaceutical company Moderna said Monday that its Covid-19 vaccine neutralizes the British and South African variants of the virus that causes that potentially fatal respiratory illness.
Results from in vitro neutralization studies showed broad effectiveness of the two-dose Moderna vaccine, which has been approved for emergency use in the United States, the European Union, the United Kingdom and elsewhere.

“Vaccination with the Moderna COVID-19 Vaccine produced neutralizing titers (antibody concentration in the blood) against all key emerging variants tested, including B.1.1.7 and B.1.351, first identified in the UK and Republic of South Africa, respectively,” the company said in a press release...